Georgii Sumtsov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Georgii Sumtsov has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Dmytro Sumtsov
Sumy Regional Clinical Oncological Dispensary, Sumy, Ukraine
4 shared publications - Igor Z. Gladchuk
Odesa national medical university, Odesa
3 shared publications - Nataliia Hyriavenko
Sumy State University, Sumy, Ukraine
3 shared publications - Kateryna Sikora
Sumy State University, Sumy, Ukraine
2 shared publications - Mykola Lyndin
Sumy State University, Sumy, Ukraine
2 shared publications Artem Skulbeda
Sumy Regional Clinical Hospital, Sumy, Ukraine
1 shared publication
Latest Publications
- Open Access
- 20 February 2024
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 39 (1) , 62-65
Fallopian Tube Hemangioma Discovered on Follow-up for Uterine Leiomyoma
Hemangioma in female reproductive organs, particularly in the fallopian tube (FT), is a sporadic disease. In this report, we describe a case of hidden capillary hemangioma in FT in a 39-year-old woman who suffered from uterine leiomyoma. During the preoperative stage, pelvic sonography, computed tomography, and diagnostic laparoscopy revealed a subserous leiomyomatous nodule located along the posterior wall of the uterus. Despite this, intraoperatively, a benign vascular neoplasm was diagnosed. Histologically, it is characterized by multiple thin-walled vascular spaces lined with a single layer of endothelial cells, in which single mitoses were observed. The diagnosis was then confirmed immunohistochemically by CD31 and CD34 expression in the endothelial cells lining the inner surface of the spaces and the low mitotic activity of the tumor cells. It is virtually impossible to diagnose this asymptomatic neoplasm before and during surgery, which can result in an inadequate number of surgeries. Incorrect interpretation of a benign tumor at a young age can lead to unnecessary radical surgery with a resulting loss of fertility, and an unrevealed malignant process can threaten life.
- 20 February 2024
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 39 (1) , 62-65
Open AccessFallopian Tube Hemangioma Discovered on Follow-up for Uterine Leiomyoma
Hemangioma in female reproductive organs, particularly in the fallopian tube (FT), is a sporadic disease. In this report, we describe a case of hidden capillary hemangioma in FT in a 39-year-old woman who suffered from uterine leiomyoma. During the preoperative stage, pelvic sonography, computed tomography, and diagnostic laparoscopy revealed a subserous leiomyomatous nodule located along the posterior wall of the uterus. Despite this, intraoperatively, a benign vascular neoplasm was diagnosed. Histologically, it is characterized by multiple thin-walled vascular spaces lined with a single layer of endothelial cells, in which single mitoses were observed. The diagnosis was then confirmed immunohistochemically by CD31 and CD34 expression in the endothelial cells lining the inner surface of the spaces and the low mitotic activity of the tumor cells. It is virtually impossible to diagnose this asymptomatic neoplasm before and during surgery, which can result in an inadequate number of surgeries. Incorrect interpretation of a benign tumor at a young age can lead to unnecessary radical surgery with a resulting loss of fertility, and an unrevealed malignant process can threaten life.
- Open Access
- 1 January 2024
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 12 (1) , 183-191
MAGNETIC RESONANCE AND COMPUTER TOMOGRAPHY IN THE DIAGNOSIS OF PRIMARY FALLOPIAN TUBE CANCER
Primary fallopian tube cancer (PTC) is a rare, highly malignant and difficult to diagnose disease. It accounts for 1.3–1.8% of all cases of cancer of the female genital organs and at least 4–6% of cancer of the uterine appendages. Epidemiological studies indicate an increase in the incidence of PTС. For example, according to American authors, from 2001 to 2014, it increased 4 times. Clinical manifestations of PTС are nonspecific and in the early stages of development, the tumor is disguised as other diseases, such as hydro-hematosalpinx, chronic inflammatory diseases, ovarian-menstrual cycle disorders, uterine leiomyoma, and others. Even in specialized oncology hospitals, reliable preoperative diagnoses range from 0 to 10-13%, and in the general medical network, even during operations, false diagnoses reach 50%. Without additional methods of examination, it is almost impossible to make a reliable diagnosis of PTС before surgery. Previously, for the purpose of diagnosing primary fallopian tube cancer, X-ray methods were used, then sonography, and nowadays magnetic resonance tomography (MRT) and computer tomography (CT) have started to be used in parallel with sonography. The aim of the study: to demonstrate cases of examination and diagnosis of primary fallopian tube cancer before surgery by MRT and to review the literature on the specified problem. Materials and methods: the study was conducted on the basis of the Sumy Regional Clinical Oncology Dispensary during 2015-2022. Four patients were examined by the magnetic resonance method and 15 women by the computer tomography method; an analysis of 26 scientific sources of the world's periodical literature on the problems of MRІ diagnosis of PTC was carried out; statistical processing of the material. Results and discussion: In almost two patients with primary fallopian tube cancer examined by MRT, correct diagnoses were made before surgery, and out of 15 examined by the CT method, only two cases revealed a suspicion of PTC. Conclusions. In the diagnosis of primary fallopian tube cancer, MRT has significantly greater capabilities than sonography and computer tomography. Первинний рак маткових труб (ПРМТ) – рідкісне, дуже злоякісне та складне для діагностики захворювання. Він становить 1,3–1,8 % усіх випадків раку жіночих статевих органів і не менше 4–6 % раку додатків матки. Епідеміологічні дослідження свідчать про зростання захворюваності на ПРМТ. Наприклад, за даними американських авторів, з 2001 по 2014 рік вона зросла у 4 рази. Клінічні прояви ПРМТ неспецифічні і на ранніх етапах розвитку пухлина маскується під інші захворювання, такі як: гідро-гематосальпінкси, хронічні запальні захворювання, порушення оваріально-менструального циклу, лейоміома матки та інше. Навіть у спеціалізованих онкологічних стаціонарах достовірні доопераційні діагнози коливаються у межах від 0 до 10−13 %, а в загальнолікувальній мережі, навіть під час операцій, помилкові діагнози досягають 50 %. Без додаткових методів обстеження поставити достовірний діагноз ПРМТ до операції практично неможливо. Раніше з метою діагностики первинного раку маткових труб застосовували рентгеноконтрастні методи, потім сонографію, а в наш час паралельно з сонографією розпочали застосовувати магнітно-резонансну (МРТ) і комп`ютерну (КТ) томографію. Мета дослідження: продемонструвати власні випадки обстеження і діагностики первинного раку маткових труб до операції методом МРТ та зробити огляд літератури по зазначеній проблемі. Матеріал і методи: дослідження проводилося на базі Сумського обласного клінічного онкологічного центру протягом 2015−2022 років. Обстежено четверо хворих методом магнітно-резонансної і 15 жінок − методом комп`ютерної томографії; проведено аналіз 26 наукових джерел періодичної літератури світу з проблеми застосування МРТ у діагностиці ПРМТ; статистична обробка матеріалу. Результати та їх обговорення: Практично у двох хворих з ПРМТ, обстежених за допомогою МРТ, поставлені правильні діагнози до операції, а з 15 обстежених методом КТ тільки у двох випадках виявлена підозра на ПРМТ. Висновки. У діагностиці первинного раку маткової труби МРТ має значно більші можливості, ніж сонографія і комп`ютерна томографія.
- 1 January 2024
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 12 (1) , 183-191
Open AccessMAGNETIC RESONANCE AND COMPUTER TOMOGRAPHY IN THE DIAGNOSIS OF PRIMARY FALLOPIAN TUBE CANCER
Primary fallopian tube cancer (PTC) is a rare, highly malignant and difficult to diagnose disease. It accounts for 1.3–1.8% of all cases of cancer of the female genital organs and at least 4–6% of cancer of the uterine appendages. Epidemiological studies indicate an increase in the incidence of PTС. For example, according to American authors, from 2001 to 2014, it increased 4 times. Clinical manifestations of PTС are nonspecific and in the early stages of development, the tumor is disguised as other diseases, such as hydro-hematosalpinx, chronic inflammatory diseases, ovarian-menstrual cycle disorders, uterine leiomyoma, and others. Even in specialized oncology hospitals, reliable preoperative diagnoses range from 0 to 10-13%, and in the general medical network, even during operations, false diagnoses reach 50%. Without additional methods of examination, it is almost impossible to make a reliable diagnosis of PTС before surgery. Previously, for the purpose of diagnosing primary fallopian tube cancer, X-ray methods were used, then sonography, and nowadays magnetic resonance tomography (MRT) and computer tomography (CT) have started to be used in parallel with sonography. The aim of the study: to demonstrate cases of examination and diagnosis of primary fallopian tube cancer before surgery by MRT and to review the literature on the specified problem. Materials and methods: the study was conducted on the basis of the Sumy Regional Clinical Oncology Dispensary during 2015-2022. Four patients were examined by the magnetic resonance method and 15 women by the computer tomography method; an analysis of 26 scientific sources of the world's periodical literature on the problems of MRІ diagnosis of PTC was carried out; statistical processing of the material. Results and discussion: In almost two patients with primary fallopian tube cancer examined by MRT, correct diagnoses were made before surgery, and out of 15 examined by the CT method, only two cases revealed a suspicion of PTC. Conclusions. In the diagnosis of primary fallopian tube cancer, MRT has significantly greater capabilities than sonography and computer tomography. Первинний рак маткових труб (ПРМТ) – рідкісне, дуже злоякісне та складне для діагностики захворювання. Він становить 1,3–1,8 % усіх випадків раку жіночих статевих органів і не менше 4–6 % раку додатків матки. Епідеміологічні дослідження свідчать про зростання захворюваності на ПРМТ. Наприклад, за даними американських авторів, з 2001 по 2014 рік вона зросла у 4 рази. Клінічні прояви ПРМТ неспецифічні і на ранніх етапах розвитку пухлина маскується під інші захворювання, такі як: гідро-гематосальпінкси, хронічні запальні захворювання, порушення оваріально-менструального циклу, лейоміома матки та інше. Навіть у спеціалізованих онкологічних стаціонарах достовірні доопераційні діагнози коливаються у межах від 0 до 10−13 %, а в загальнолікувальній мережі, навіть під час операцій, помилкові діагнози досягають 50 %. Без додаткових методів обстеження поставити достовірний діагноз ПРМТ до операції практично неможливо. Раніше з метою діагностики первинного раку маткових труб застосовували рентгеноконтрастні методи, потім сонографію, а в наш час паралельно з сонографією розпочали застосовувати магнітно-резонансну (МРТ) і комп`ютерну (КТ) томографію. Мета дослідження: продемонструвати власні випадки обстеження і діагностики первинного раку маткових труб до операції методом МРТ та зробити огляд літератури по зазначеній проблемі. Матеріал і методи: дослідження проводилося на базі Сумського обласного клінічного онкологічного центру протягом 2015−2022 років. Обстежено четверо хворих методом магнітно-резонансної і 15 жінок − методом комп`ютерної томографії; проведено аналіз 26 наукових джерел періодичної літератури світу з проблеми застосування МРТ у діагностиці ПРМТ; статистична обробка матеріалу. Результати та їх обговорення: Практично у двох хворих з ПРМТ, обстежених за допомогою МРТ, поставлені правильні діагнози до операції, а з 15 обстежених методом КТ тільки у двох випадках виявлена підозра на ПРМТ. Висновки. У діагностиці первинного раку маткової труби МРТ має значно більші можливості, ніж сонографія і комп`ютерна томографія.
- 28 November 2023
- Published by Springer Nature in Wiener Medizinische Wochenschrift
- Vol. 174 (9-10) , 199-207
Rare non-serous fallopian tube cancers: institutional experience and literature review
Summary Introduction We reviewed 63 reports from the literature on rare non-serous tumors of the fallopian tubes and carried out a comparative analysis of clinical manifestations and diagnostic methods. We also report our observations from patients with these tumors. Materials and methods Of 157 patients with primary fallopian tube cancer (FTC) treated in our regional oncological hospital between 1970 and 2020, there were nine (6%) cases of rare non-serous cancers, including one case each of choriocarcinoma, carcinosarcoma, and neuroendocrine tumor, and two cases each of non-keratinizing squamous cell carcinoma, mucinous adenocarcinoma, and clear cell adenocarcinoma. Results For carcinosarcoma and squamous cell, clear cell, and transitional cell carcinomas, clinical history, patient age, and clinical manifestations were similar to the main group of FTCs. Choriocarcinoma differed significantly from other cancers of the fallopian tubes in terms of patient age and clinical course. Mucinous adenocarcinoma, mesothelioma, and borderline tumors, with rare exceptions, were almost always asymptomatic and were found only incidentally during surgery. Choriocarcinoma and carcinosarcoma had an aggressive course, while squamous cell, transitional cell, clear cell, and mucinous carcinomas were less aggressive. Since most rare non-serous tumors have a similar disease course to typical FTCs and there is a lack of appropriate treatment protocols for rare tumors, treatment options developed for ovarian tumors and FTC are justified for these tumors. Conclusion Rare non-serous malignant fallopian tube tumors are very similar to serous and endometrioid FTC in terms of clinical manifestations and diagnosis.
- 28 November 2023
- Published by Springer Nature in Wiener Medizinische Wochenschrift
- Vol. 174 (9-10) , 199-207
Rare non-serous fallopian tube cancers: institutional experience and literature review
Summary Introduction We reviewed 63 reports from the literature on rare non-serous tumors of the fallopian tubes and carried out a comparative analysis of clinical manifestations and diagnostic methods. We also report our observations from patients with these tumors. Materials and methods Of 157 patients with primary fallopian tube cancer (FTC) treated in our regional oncological hospital between 1970 and 2020, there were nine (6%) cases of rare non-serous cancers, including one case each of choriocarcinoma, carcinosarcoma, and neuroendocrine tumor, and two cases each of non-keratinizing squamous cell carcinoma, mucinous adenocarcinoma, and clear cell adenocarcinoma. Results For carcinosarcoma and squamous cell, clear cell, and transitional cell carcinomas, clinical history, patient age, and clinical manifestations were similar to the main group of FTCs. Choriocarcinoma differed significantly from other cancers of the fallopian tubes in terms of patient age and clinical course. Mucinous adenocarcinoma, mesothelioma, and borderline tumors, with rare exceptions, were almost always asymptomatic and were found only incidentally during surgery. Choriocarcinoma and carcinosarcoma had an aggressive course, while squamous cell, transitional cell, clear cell, and mucinous carcinomas were less aggressive. Since most rare non-serous tumors have a similar disease course to typical FTCs and there is a lack of appropriate treatment protocols for rare tumors, treatment options developed for ovarian tumors and FTC are justified for these tumors. Conclusion Rare non-serous malignant fallopian tube tumors are very similar to serous and endometrioid FTC in terms of clinical manifestations and diagnosis.
- Open Access
- 22 July 2021
- Published by Publishing Office TRILIST in Reproductive Endocrinology
- No. 59,p. 66-71
Problems of primary fallopian tube cancer diagnostics during and after surgery
To date, the reliable diagnoses primary fallopian tube cancer (PFTC) before surgery range from 0% to 10–15%. Number of misdiagnosis even during operations reaches 30–50% and PFTC is often disguised as innocent hydro-hematosalpinx or other diseases. Research objective: to study the possibilities of PFTC diagnosis during laparotomy and laparoscopy, macroscopic examination of removed macrodrugs, suboperative use of morphological studies, problems of histological interpretation of PFTC after surgery. Materials and methods. During the period from 1966 to 2020 authors of article selected and retrospectively studied quite informative medical histories of 105 patients with PFTC aged 34 to 78 years (mean age 55.8 years). All patients were operated. Revision of the pelvic organs and abdominal cavity was performed during operations. Removed macrodrugs were examined macroscopically and histologically. According to the indications during operations histological and cytological methods of rapid diagnosis were used. Immunohistochemical methods were used to interpret rare and difficult to diagnose tumors after surgery. Results. Only 7 (6.6%) from 105 patients with PFTC was not recognized during surgery, and 18 (17.1%) were diagnosed only after suboperative histological examination. Errors during operations in the initial PFTC forms (without careful study of macrodrugs and suboperative morphological examination) can reach 23.8%. Problems with the primary lession interpretation, which arose in 11 (10.5%) patients with a pronounced tumor process, did not prevent the choice of adequate surgery. The tumor dissemination of the fallopian tube outside was detected in 69 (72.4%) patients, in 25 (26.2%) among them there were lymph node metastases. Conclusion. Careful revision of the abdominal organs and macroscopic examination of removed drugs using suboperative morphological studies avoids errors in the diagnosis and surgical treatment of patients with PFTC.
- 22 July 2021
- Published by Publishing Office TRILIST in Reproductive Endocrinology
- No. 59,p. 66-71
Open AccessProblems of primary fallopian tube cancer diagnostics during and after surgery
To date, the reliable diagnoses primary fallopian tube cancer (PFTC) before surgery range from 0% to 10–15%. Number of misdiagnosis even during operations reaches 30–50% and PFTC is often disguised as innocent hydro-hematosalpinx or other diseases. Research objective: to study the possibilities of PFTC diagnosis during laparotomy and laparoscopy, macroscopic examination of removed macrodrugs, suboperative use of morphological studies, problems of histological interpretation of PFTC after surgery. Materials and methods. During the period from 1966 to 2020 authors of article selected and retrospectively studied quite informative medical histories of 105 patients with PFTC aged 34 to 78 years (mean age 55.8 years). All patients were operated. Revision of the pelvic organs and abdominal cavity was performed during operations. Removed macrodrugs were examined macroscopically and histologically. According to the indications during operations histological and cytological methods of rapid diagnosis were used. Immunohistochemical methods were used to interpret rare and difficult to diagnose tumors after surgery. Results. Only 7 (6.6%) from 105 patients with PFTC was not recognized during surgery, and 18 (17.1%) were diagnosed only after suboperative histological examination. Errors during operations in the initial PFTC forms (without careful study of macrodrugs and suboperative morphological examination) can reach 23.8%. Problems with the primary lession interpretation, which arose in 11 (10.5%) patients with a pronounced tumor process, did not prevent the choice of adequate surgery. The tumor dissemination of the fallopian tube outside was detected in 69 (72.4%) patients, in 25 (26.2%) among them there were lymph node metastases. Conclusion. Careful revision of the abdominal organs and macroscopic examination of removed drugs using suboperative morphological studies avoids errors in the diagnosis and surgical treatment of patients with PFTC.